Latest Updates
- 20. November 2009
European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer - 20. November 2009
ACTEMRA Improves Signs and Symptoms in Children with Systemic Onset Juvenile Idiopathic Arthritis (sJIA) - 18. November 2009
US FDA issues complete response letter for Rituxan/MabThera for chronic lymphocytic leukaemia
Mission & Goals
Roche maintains open and honest relationships with our shareholders, prospective investors and the wider investment community. The role of Investor Relations is to manage these relationships efficiently, transparently and consistently in accordance with company polices and relevant securities rules and laws. more
Services
- Send E-Mail
- IR Team
- RSS-Feeds
- Roche Events Podcast
- Subscribe to IR News
- Follow Roche on Twitter
- Roche Finance Info System
Learn more about:
- Corporate Overview for Investors
- Our annual and seminannual report
- Investor events on our R&D pipeline
- Frequently Asked Questions
Roche recognised as Health care Super Sector Leader in Dow Jones Sustainability Index
Selection places Roche as one of the most sustainable healthcare company's worldwide. Read more